Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Gaetano Pezzicoli, Elisabetta Filoni, Angela Gernone, Laura Cosmai, Mimma Rizzo & Camillo Porta. (2021) Playing the Devil’s Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors. Cancer Management and Research 13, pages 7623-7636.
Read now
Read now
Yejing Hong, Liangliang Gong, Biying Yu & Yishan Dong. (2021) PPM1A suppresses the proliferation and invasiveness of RCC cells via Smad2/3 signaling inhibition. Journal of Receptors and Signal Transduction 41:3, pages 245-254.
Read now
Read now
Articles from other publishers (14)
Gaetano Pezzicoli, Federica Ciciriello, Vittoria Musci, Francesco Salonne, Anna Ragno & Mimma Rizzo. (2023) Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma. Current Oncology 30:10, pages 9276-9290.
Crossref
Crossref
Lei Han, Zeyong Huang, Yan Liu, Lijuan Ye, Dongqi Li, Zhihong Yao, Cao Wang, Ya Zhang, Hang Yang, Zunxian Tan, Jiadai Tang & Zuozhang Yang. (2021) MicroRNA-106a regulates autophagy-related cell death and EMT by targeting TP53INP1 in lung cancer with bone metastasis. Cell Death & Disease 12:11.
Crossref
Crossref
Raviprakash Tumkur Sitaram, Maréne Landström, Göran Roos & Börje Ljungberg. (2021) Significance of PI3K signalling pathway in clear cell renal cell carcinoma in relation to VHL and HIF status. Journal of Clinical Pathology 74:4, pages 216-222.
Crossref
Crossref
Demin Fan, Qiang Liu, Fei Wu, Na Liu, Hongyi Qu, Yijiao Yuan, Yong Li, Huayu Gao, Juntao Ge, Yue Xu, Hao Wang, Qingyong Liu & Zuohui Zhao. (2020) Prognostic significance of PI3K/AKT/ mTOR signaling pathway members in clear cell renal cell carcinoma. PeerJ 8, pages e9261.
Crossref
Crossref
Steffen Rausch, Daniel Schollenberger, Joerg Hennenlotter, Viktoria Stühler, Stephan Kruck, Arnulf Stenzl & Jens Bedke. (2018) mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance. Journal of Cancer Research and Clinical Oncology 145:1, pages 153-163.
Crossref
Crossref
Hojung Lee. (2017) Phosphorylated mTOR Expression Profiles in Human Normal and Carcinoma Tissues. Disease Markers 2017, pages 1-8.
Crossref
Crossref
Tsukasa Igawa. (2017) Role of protein phosphatases in genitourinary cancers. International Journal of Urology 24:1, pages 16-24.
Crossref
Crossref
Huiqiang Wang, Bin Chen, Bo Duan, Jiaxin Zheng & Xinyi Wu. (2016) miR-205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma. Molecular Medicine Reports 14:4, pages 3343-3349.
Crossref
Crossref
Ryogo Minamimoto, Noboru Nakaigawa, Yoji Nagashima, Jun Toyohara, Daiki Ueno, Kazuhiro Namura, Kazuhiko Nakajima, Masahiro Yao & Kazuo Kubota. (2016) Comparison of 11C-4DST and 18F-FDG PET/CT imaging for advanced renal cell carcinoma: preliminary study. Abdominal Radiology 41:3, pages 521-530.
Crossref
Crossref
Ahmed Q. Haddad, Payal Kapur, Nirmish Singla, Jay D. Raman, Matthew T. Then, Philipp Nuhn, Alexander Buchner, Patrick Bastian, Christian Seitz, Shahrokh F. Shariat, Karim Bensalah, Nathalie Rioux-Leclercq, Arthur Sagalowsky, Yair Lotan & Vitaly Margulis. (2015) Validation of mammalian target of rapamycin biomarker panel in patients with clear cell renal cell carcinoma. Cancer 121:1, pages 43-50.
Crossref
Crossref
MEILING WEN, BAOXIU LI, XIAOFEI CAO, CHENGYIN WENG, YONG WU, XISHENG FANG, XIAOSHI ZHANG & GUOLONG LIU. (2014) Clinical significance of aberrant mammalian target of rapamycin expression in stage IIIB colon cancer. Oncology Letters 8:3, pages 1080-1086.
Crossref
Crossref
J Stebbing, L C Lit, H Zhang, R S Darrington, O Melaiu, B Rudraraju & G Giamas. (2013) The regulatory roles of phosphatases in cancer. Oncogene 33:8, pages 939-953.
Crossref
Crossref
James L. Chen, Daniel E. Appelbaum, Masha Kocherginsky, Charles L. Cowey, Wendy Kimryn Rathmell, David F. McDermott & Walter M. Stadler. (2013)
FDG
‐
PET
as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer
. Cancer Medicine 2:4, pages 545-552.
Crossref
Crossref
Qingqing Cai, Haixia Deng, Dan Xie, Tianxin Lin & Tongyu Lin. (2012) Phosphorylated AKT Protein Is Overexpressed in Human Peripheral T-cell Lymphomas and Predicts Decreased Patient Survival. Clinical Lymphoma Myeloma and Leukemia 12:2, pages 106-112.
Crossref
Crossref